Cooper Financial Group Moderna, Inc. Transaction History

Cooper Financial Group

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$117.13 - $176.59 $150,746 - $227,271	-1,287 Closed	0 $0
Q1 2022 Apr 12, 2022	SELL	$126.46 - $235.05 $142,393 - $264,666	-1,126 Reduced 46.66%	1,287 $222,000
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $39,292 - $64,120	174 Added 7.77%	2,413 $613,000
Q2 2021 Jul 12, 2021	BUY	$129.91 - $234.98 $5,066 - $9,164	39 Added 1.77%	2,239 $526,000
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $98,917 - $168,497	-906 Reduced 29.17%	2,200 $288,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $204,188 - $527,585	3,106 New	3,106 $324,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

Stay updated on Cooper Financial Group with notifications on news.